Atlas Trials

Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders)

Clinical trial NCT05137938 · COMPLETED

Trial details

NCT number
NCT05137938
Sponsor
Centre for Addiction and Mental Health
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Depression
Start date
2021-10-25
Primary completion
2023-07-24
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.